NCT05809908: An ongoing trial by Cerecin
This trial is ongoing. It must report results 3 years, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05809908 |
|---|---|
| Title | A Phase 3, 26-Week, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Daily Administration of Tricaprilin as AC-OLE-01-VA in Participants With Mild to Moderate Alzheimer's Disease Dementia |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 31, 2026 |
| Completion date | June 30, 2029 |
| Required reporting date | June 30, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Oct. 21, 2026 |
| Days late | None |